Phillip N Newsome
34PUBLICATIONS
154CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (34)
Sort by Publication Date:
|Jun 20, 2025
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease.Jimmy Che-To Lai, Boyu Yang, Hye Won Lee
|Jun 11, 2025
Cardiovascular Risk Assessment Tools are Insufficient for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.A Sidney Barritt, Elliot B Tapper, Philip N Newsome
|Feb 19, 2025
NAFLD vs MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)-Why the Need for a Change of Nomenclature?Amalia Gastaldelli, Philip N Newsome
|Oct 16, 2024
Semaglutide 2.4 mg in Participants With Metabolic Dysfunction-Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 ESSENCE Trial.Philip N Newsome, Arun J Sanyal, Kristiane A Engebretsen
|Oct 03, 2024
Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis.Paul Horn, Jenny Norlin, Kasper Almholt
|Aug 01, 2024
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease.Xiao-Dong Zhou, Seung Up Kim, Terry Cheuk-Fung Yip
Pageof 6
Frequent Collaborators
7 joint publications
Vincent Wai-Sun Wong
7 joint publications
Jörn M Schattenberg
5 joint publications
Jérôme Boursier
4 joint publications
Elisabetta Bugianesi
4 joint publications
Salvatore Petta
4 joint publications
Hannes Hagström
3 joint publications
Aleksander Krag
3 joint publications
Paul Horn
3 joint publications
Emmanuel Tsochatzis
3 joint publications
Alina M Allen
